Catherine Shoults
Investitore di Private Equity presso Symbiosis Capital Management LLC
Profilo
Catherine focuses on creating cloud-based tools and automation using Artificial Intelligence and Machine Learning to support investment and operational processes across the firm.
Prior to SymBiosis, she was the Director of Drug Development at Orbis Biosciences, where she led regulatory, pre-clinical, and clinical development.
Her drug development career started at Quintiles (IQVIA) in Phase I clinical development.
She earned her PhD in Biomedical Informatics with an emphasis in Artificial Intelligence and Natural Language Processing from the University of Arkansas for Medical Sciences, an MPH with an emphasis in Epidemiology of Microbial Disease from Yale University, and a BS in Biology with a minor in Chemistry from Missouri State University.
Posizioni attive di Catherine Shoults
Società | Posizione | Inizio |
---|---|---|
Symbiosis Capital Management LLC
Symbiosis Capital Management LLC Investment ManagersFinance Symbiosis Capital Management LLC (SymBiosis) is a venture capital firm founded in 2019. The firm is headquartered in Bentonville, Arkansas. | Investitore di Private Equity | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Symbiosis Capital Management LLC
Symbiosis Capital Management LLC Investment ManagersFinance Symbiosis Capital Management LLC (SymBiosis) is a venture capital firm founded in 2019. The firm is headquartered in Bentonville, Arkansas. | Finance |
- Borsa valori
- Insiders
- Catherine Shoults